source
- Atara, Pierre Fabre's cell therapy to get another shot at FDA approvalThere's new life for a twice-rejected T cell therapy from Atara Biotherapeutics and Pierre Fabre Pharmaceuticals. US regulators are willing to reconsider using a Phase 3 study as the basis for an a…Endpoints · 2mo ago↗ source
- STAT+: OpenAI’s health policy wishlist, CGM news from Dexcom, and moreIn this edition of STAT Health Tech: A health policy blueprint from OpenAI, CGM updates from Dexcom, and push back against whole body scans.STAT · 2mo ago↗ source
- Pennsylvania sues AI chatbot company for posing as a licensed doctorThe state of Pennsylvania has sued Character.AI, a startup that lets users chat with different AI-generated personas, for illegally presenting a chatbot as a licensed doctor in the state. This is t…